Skip to main content

Operative Indications and Pitfalls in Patient Selection for Surgery of Pituitary Tumors

  • Chapter
  • First Online:
Transsphenoidal Surgery

Abstract

The overall goals of pituitary tumor surgery are to reverse any endocrinopathy, restore the normal pituitary function, relieve mass effect, reestablish normal neurological status, determine a diagnosis, and resect as much tumor as possible to minimize the chance of recurrence. Preoperative evaluation of a patient with a pituitary lesion is critical for identifying patients that are potential candidates for surgery. This chapter evaluates the surgical indications for patients with pituitary tumors and identifies the precautions that must be adhered to when dealing with various types of pituitary tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Nemergut EC. 3 – principles and pitfalls of anesthesia for transsphenoidal surgery. In: Lanzino ERL, editor. Transsphenoidal surgery. Saint Louis: W.B. Saunders; 2010. p. 10–21.

    Chapter  Google Scholar 

  2. Rand T, Kink E, Sator M, et al. MRI of microadenomas in patients with hyperprolactinaemia. Neuroradiology. 1996;38(8):744–6.

    Article  CAS  Google Scholar 

  3. Griessenauer CJ, Raborn J, Mortazavi MM, et al. Relationship between the pituitary stalk angle in prefixed, normal, and postfixed optic chiasmata: an anatomic study with microsurgical application. Acta Neurochir. 2014;156(1):147–51. doi:10.1007/s00701-013-1944-1.

    Article  PubMed  Google Scholar 

  4. Chandler WF, Barkan AL. Treatment of pituitary tumors: a surgical perspective. Endocrinol Metab Clin North Am. 2008;37(1):51–66, viii. doi:10.1016/j.ecl.2007.10.006.

  5. Evanson J. Radiology of the pituitary. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext. South Dartmouth: MDText.com, Inc; 2000.

    Google Scholar 

  6. Oystese KA, Evang JA, Bollerslev J. Non-functioning pituitary adenomas: growth and aggressiveness. Endocrine. 2016; doi:10.1007/s12020-016-0940-7.

    Article  PubMed  Google Scholar 

  7. Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9(3):367–73.

    Article  CAS  Google Scholar 

  8. Buchfelder M, Schlaffer S. Surgical treatment of pituitary tumours. Best Pract Res Clin Endocrinol Metab. 2009;23(5):677–92. doi:10.1016/j.beem.2009.05.002.

    Article  PubMed  Google Scholar 

  9. Buchfelder M. Treatment of pituitary tumors: surgery. Endocrine. 2005;28(1):67–75. ENDO:28:1:067 [pii].

    Google Scholar 

  10. Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology. 2006;83(3–4):230–9. 95533 [pii].

    Article  Google Scholar 

  11. Shimon I, Cohen ZR, Ram Z, et al. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery. 2001;48(6):1239–43; discussion 1244–5.

    Google Scholar 

  12. Park SS, Becker DG. 6 – rhinological evaluation. In: Laws ER, Lanzino G, editors. Transsphenoidal surgery. Saint Louis: W.B. Saunders; 2010. p. 36–42.

    Chapter  Google Scholar 

  13. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol. 2005;152(3):379–87. 152/3/379 [pii].

    Article  CAS  Google Scholar 

  14. Chen JC, Amar AP, Choi S, et al. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg. 2003;98(5):967–73. doi:10.3171/jns.2003.98.5.0967.

    Article  PubMed  Google Scholar 

  15. Nomikos P, Ladar C, Fahlbusch R, et al. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir. 2004;146(1):27–35. doi:10.1007/s00701-003-0174-3.

    Article  CAS  PubMed  Google Scholar 

  16. Webb SM, Rigla M, Wagner A, et al. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab. 1999;84(10):3696–700. doi:10.1210/jcem.84.10.6019.

    Article  CAS  PubMed  Google Scholar 

  17. Kattah JC. 5 – the neuro-ophthalmology of pituitary tumors. In: Lanzino ERL, editor. Transsphenoidal surgery. Saint Louis: W.B. Saunders; 2010. p. 28–35.

    Chapter  Google Scholar 

  18. Stark KL, Kaufman B, Lee BC, et al. Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. J AAPOS. 1999;3(6):366–71. S1091853199000129 [pii].

    Article  CAS  Google Scholar 

  19. Tantiwongkosi B, Mafee MF. Imaging of optic neuropathy and chiasmal syndromes. Neuroimaging Clin N Am. 2015;25(3):395–410. doi:10.1016/j.nic.2015.05.004.

    Article  PubMed  Google Scholar 

  20. Horton JC. Wilbrand’s knee of the primate optic chiasm is an artefact of monocular enucleation. Trans Am Ophthalmol Soc. 1997;95:579–609.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol. 1994;41(3):359–64.

    Article  CAS  Google Scholar 

  22. Schlechte JA. Prolactinoma. Curr Ther Endocrinol Metab. 1997;6:45–7.

    CAS  PubMed  Google Scholar 

  23. Colao A, Vitale G, Cappabianca P, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab. 2004;89(4):1704–11. doi:10.1210/jc.2003-030979.

    Article  CAS  PubMed  Google Scholar 

  24. Colao A, Sarno AD, Cappabianca P, et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol. 2003;148(3):325–31.

    Article  CAS  Google Scholar 

  25. Jallad RS, Musolino NR, Kodaira S, et al. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue? Clin Endocrinol. 2007;67(2):310–5. CEN2885 [pii].

    Article  CAS  Google Scholar 

  26. Barkan AL, Lloyd RV, Chandler WF, et al. Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab. 1988;67(5):1040–8. doi:10.1210/jcem-67-5-1040.

    Article  CAS  PubMed  Google Scholar 

  27. Khaldi M, Ben Hamouda K, Jemel H, et al. Pituitary apoplexy. Report of 25 patients. Neurochirurgie. 2006;52(4):330–8. MDOI-NCHIR-09-2006-52-4-0028-3770-101019-200604684 [pii].

    Article  CAS  Google Scholar 

  28. Matta MP, Caron P. Acromegalic cardiomyopathy: a review of the literature. Pituitary. 2003;6(4):203–7.

    Article  CAS  Google Scholar 

  29. Colao A, Marzullo P, Di Somma C, et al. Growth hormone and the heart. Clin Endocrinol. 2001;54(2):137–54. cen1218 [pii].

    Article  CAS  Google Scholar 

  30. Rajasoorya C, Holdaway IM, Wrightson P, et al. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41(1):95–102.

    Article  CAS  Google Scholar 

  31. Damjanovic SS, Neskovic AN, Petakov MS, et al. High output heart failure in patients with newly diagnosed acromegaly. Am J Med. 2002;112(8):610–6. S000293430201094X [pii].

    Article  Google Scholar 

  32. Colao A, Cuocolo A, Marzullo P, et al. Impact of patient’s age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J Clin Endocrinol Metab. 1999;84(5):1518–23. doi:10.1210/jcem.84.5.5674.

    Article  CAS  PubMed  Google Scholar 

  33. Lopez-Velasco R, Escobar-Morreale HF, Vega B, et al. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab. 1997;82(4):1047–53. doi:10.1210/jcem.82.4.3876.

    Article  CAS  PubMed  Google Scholar 

  34. Guilleminault C, van den Hoed J. Acromegaly and narcolepsy. Lancet. 1979;2(8145):750–1. S0140–6736(79)90684–6 [pii].

    Article  CAS  Google Scholar 

  35. Kitahata LM. Airway difficulties associated with anaesthesia in acromegaly. Three case reports. Br J Anaesth. 1971;43(12):1187–90.

    Article  CAS  Google Scholar 

  36. Quabbe HJ, Plockinger U. Metabolic aspects of acromegaly and its treatment. Metabolism. 1996;45(8 Suppl 1):61–2.

    Article  CAS  Google Scholar 

  37. Ross EJ, Marshall-Jones P, Friedman M. Cushing’s syndrome: diagnostic criteria. Q J Med. 1966;35(138):149–92.

    CAS  PubMed  Google Scholar 

  38. Sugihara N, Shimizu M, Kita Y, et al. Cardiac characteristics and postoperative courses in Cushing’s syndrome. Am J Cardiol. 1992;69(17):1475–80.

    Article  CAS  Google Scholar 

  39. Smith M, Hirsch NP. Pituitary disease and anaesthesia. Br J Anaesth. 2000;85(1):3–14.

    Article  CAS  Google Scholar 

  40. Caron P, Arlot S, Bauters C, et al. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 2001;86(6):2849–53. doi:10.1210/jcem.86.6.7593.

    Article  CAS  PubMed  Google Scholar 

  41. Vance ML. Perioperative management of patients undergoing pituitary surgery. Endocrinol Metab Clin N Am. 2003;32(2):355–65.

    Article  Google Scholar 

  42. Jane Jr JA, Laws Jr ER. Surgical management of pituitary adenomas. Singap Med J. 2002;43(6):318–23.

    Google Scholar 

  43. Chuang CC, Chang CN, Wei KC, et al. Surgical treatment for severe visual compromised patients after pituitary apoplexy. J Neuro-Oncol. 2006;80(1):39–47. doi:10.1007/s11060-006-9148-7.

    Article  Google Scholar 

  44. Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 2007;109(1):63–70. S0303–8467(06)00011–4 [pii].

    Article  Google Scholar 

  45. Park P, Chandler WF, Barkan AL, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery. 2004;55(1):100–6; discussion 106–7.

    Google Scholar 

  46. Wilson CB. Surgical management of pituitary tumors. J Clin Endocrinol Metab. 1997;82(8):2381–5. doi:10.1210/jcem.82.8.4188.

    Article  CAS  PubMed  Google Scholar 

  47. Jane JA Jr, Thapar K, Kaptain GJ, et al. Pituitary surgery: transsphenoidal approach. Neurosurgery. 2002;51(2):435–42; discussion 442–4.

    Google Scholar 

  48. Saeki N, Nakamura M, Sunami K, et al. Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment. Endocr J. 1998;45(4):529–37.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Eseonu, C., Jackson, C., Quinones-Hinojosa, A. (2017). Operative Indications and Pitfalls in Patient Selection for Surgery of Pituitary Tumors. In: Laws, Jr, E.R., Cohen-Gadol, A.A., Schwartz, T.H., Sheehan, J.P. (eds) Transsphenoidal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-56691-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56691-7_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56689-4

  • Online ISBN: 978-3-319-56691-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics